PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 59 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $31,000 | +3.3% | 8,891 | +0.3% | 0.00% | – |
| Q4 2020 | $30,000 | -6.2% | 8,867 | -2.8% | 0.00% | – |
| Q3 2020 | $32,000 | -23.8% | 9,122 | -0.3% | 0.00% | – |
| Q2 2020 | $42,000 | +55.6% | 9,150 | +12.6% | 0.00% | – |
| Q1 2020 | $27,000 | -48.1% | 8,123 | -5.5% | 0.00% | – |
| Q4 2019 | $52,000 | +44.4% | 8,592 | -0.8% | 0.00% | – |
| Q3 2019 | $36,000 | -68.7% | 8,664 | -0.7% | 0.00% | – |
| Q2 2019 | $115,000 | – | 8,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|